These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10178645)

  • 21. [Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
    Hoomans T; van der Roer N; Severens JL; Delwel GO
    Ned Tijdschr Geneeskd; 2010; 154():A958. PubMed ID: 20699045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of pharmacoeconomics: bridging science and practice.
    Drummond MF
    Clin Ther; 1996; 18(5):969-78; discussion 968. PubMed ID: 8930435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
    Lipsy RJ
    Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The practical impact of pharmacoeconomics on institutional managers.
    Cooke J
    Pharmacoeconomics; 1994 Oct; 6(4):289-97. PubMed ID: 10147466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacoeconomics: state of the art in 1997.
    Schulman KA; Linas BP
    Annu Rev Public Health; 1997; 18():529-48. PubMed ID: 9143730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of pharmacoeconomics and pharmaceutical outcomes evaluations.
    Reeder CE
    Am J Health Syst Pharm; 1995 Oct; 52(19 Suppl 4):S5-8. PubMed ID: 8846244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of pharmacoeconomics in current Indian healthcare system.
    Ahmad A; Patel I; Parimilakrishnan S; Mohanta GP; Chung H; Chang J
    J Res Pharm Pract; 2013 Jan; 2(1):3-9. PubMed ID: 24991597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No immediate pain relief for the pharmaceutical industry.
    Ahlborn H; Henderson S; Davies N
    Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of comparative effectiveness research in Asia, Europe, and North America.
    Patel I; Rarus R; Tan X; Lee EK; Guy J; Ahmad A; Chang J
    Indian J Pharmacol; 2015; 47(6):585-93. PubMed ID: 26729947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?
    Drummond MF
    Pharmacoeconomics; 1998 Jul; 14(1):1-9. PubMed ID: 10182189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacoeconomic picture in Saudi Arabia.
    Alkhenizan A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):483-90. PubMed ID: 24953076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacoeconomics: an emerging discipline.
    Letizia C
    Qual Assur; 1995 Mar; 4(1):68-74. PubMed ID: 8520866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacoeconomics of appropriate antimicrobial use.
    Davey P
    Diagn Microbiol Infect Dis; 1995; 22(1-2):225-9. PubMed ID: 7587044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacoeconomics: the new dismal science.
    Luchins DJ
    Adm Policy Ment Health; 2004 May; 31(5):425-7. PubMed ID: 15379388
    [No Abstract]   [Full Text] [Related]  

  • 35. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.
    Alzarea AI; Khan YH; Alanazi AS; Butt MH; Almalki ZS; AlAhmari AK; Alsahali S; Mallhi TH
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacoeconomics].
    Shiragami M
    Yakugaku Zasshi; 2003 Mar; 123(3):133-42. PubMed ID: 12693013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature.
    Sanchez LA
    Am J Health Syst Pharm; 1999 Aug; 56(16):1630-8; quiz 1638-40. PubMed ID: 10459385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pricing medicines: theory and practice, challenges and opportunities.
    Gregson N; Sparrowhawk K; Mauskopf J; Paul J
    Nat Rev Drug Discov; 2005 Feb; 4(2):121-30. PubMed ID: 15688076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economics, pharmaceuticals, and pharmacoeconomics.
    Johannesson M; O'Brien BJ
    Med Decis Making; 1998; 18(2 Suppl):S1-3. PubMed ID: 9566460
    [No Abstract]   [Full Text] [Related]  

  • 40. Medicine, pharmacy, and industry--a fly's eye view of health care.
    Halperin JA
    Ann Pharmacother; 1995 Sep; 29(9):925-33. PubMed ID: 8547743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.